Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - Vyant Bio, Inc. | d254016ds1a.htm |
| EX-10.36 - STOCK PURCHASE WARRANT - Vyant Bio, Inc. | d254016dex1036.htm |
| EX-10.34 - FORM OF PROMISSORY NOTE - Vyant Bio, Inc. | d254016dex1034.htm |
| EX-10.39 - AMENDMENT TO CREDIT AGREEMENT - Vyant Bio, Inc. | d254016dex1039.htm |
| EX-10.37 - INTER-CREDITOR AGREEMENT - Vyant Bio, Inc. | d254016dex1037.htm |
| EX-10.33 - AMENDED AND RESTATED CREDIT AGREEMENT - Vyant Bio, Inc. | d254016dex1033.htm |
| EX-10.38 - SEVENTH ADDENDUM TO CREDIT AGREEMENT - Vyant Bio, Inc. | d254016dex1038.htm |
| EX-10.35 - FORM OF PROMISSORY NOTE - Vyant Bio, Inc. | d254016dex1035.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 2 to the Registration Statement (No. 333-178836) on Form S-1 of Cancer Genetics, Inc. and subsidiary of our report dated March 13, 2012, relating to our audits of the consolidated financial statements, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the caption “Experts” in such Prospectus.
| /s/ McGladrey & Pullen, LLP |
| Des Moines, Iowa |
| March 13, 2012 |